Ardaman Shergill to Neoplasm Grading
This is a "connection" page, showing publications Ardaman Shergill has written about Neoplasm Grading.
Connection Strength
0.097
-
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
Score: 0.048
-
Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy. JCO Precis Oncol. 2024 Sep; 8:e2400149.
Score: 0.048